Skip to main content

Peer Review reports

From: Improving the understanding of how patients with non-dystrophic myotonia are selected for myotonia treatment with mexiletine (NaMuscla): outcomes of treatment impact using a European Delphi panel

Original Submission
23 Apr 2021 Submitted Original manuscript
17 May 2021 Reviewed Reviewer Report - David Arnold
6 Jun 2021 Reviewed Reviewer Report
10 Jun 2021 Reviewed Reviewer Report
6 Aug 2021 Author responded Author comments - Marieke Schurer
Resubmission - Version 2
6 Aug 2021 Submitted Manuscript version 2
3 Sep 2021 Author responded Author comments - Marieke Schurer
Resubmission - Version 3
3 Sep 2021 Submitted Manuscript version 3
10 Sep 2021 Author responded Author comments - Marieke Schurer
Resubmission - Version 4
10 Sep 2021 Submitted Manuscript version 4
2 Oct 2021 Reviewed Reviewer Report
20 Oct 2021 Author responded Author comments - Marieke Schurer
Resubmission - Version 5
20 Oct 2021 Submitted Manuscript version 5
2 Nov 2021 Author responded Author comments - Marieke Schurer
Resubmission - Version 6
2 Nov 2021 Submitted Manuscript version 6
Publishing
10 Nov 2021 Editorially accepted
1 Dec 2021 Article published 10.1186/s12883-021-02491-3

You can find further information about peer review here.

Back to article page